Skip to main content
Top
Published in: Journal of Nuclear Cardiology 6/2012

01-12-2012 | Original Article

The evolving practice of nuclear cardiology: Results from the 2011 ASNC member survey

Authors: Peter Tilkemeier, MD, Jacqueline Green, MD, MPH, Andrew J. Einstein, MD, PhD, Reza Fazel, MD, MSc, Patricia Reames, RTR, CNMT, NCT, Leslee J. Shaw, PhD

Published in: Journal of Nuclear Cardiology | Issue 6/2012

Login to get access

Abstract

Background

Today’s imaging laboratories face challenges including reimbursement, prior authorization, and accreditation standards. The impact on the practice of nuclear cardiology in the United States is unknown. We conducted a survey of ASNC members to provide a snapshot of nuclear cardiology imaging laboratories in 2011.

Methods and Results

The survey identified practice patterns including personnel, volumes, protocols used, and laboratory characteristics. We employed random sampling methodology stratified geographically. The response rate was 19.5% (73/374 laboratories). A non-random survey conducted in 2001 of 25 laboratories served as a comparator. A total of 73 laboratories, representing 202 physicians and 177 technologists responded. The reported median procedural volume was 1,225 studies annually; 88.9% of laboratories were accredited. Compared with 2001, dual isotope imaging protocol use dropped from 72% to 15.6%. Five markers of quality were surveyed. Half of laboratories use the American College of Cardiology’s Appropriate Use Criteria, 61% used segmental scoring, and 32% provided guidance on post-test therapeutic management. 89% perform catheterization correlations while only 33% implemented radiation dose tracking.

Conclusions

This survey of ASNC members provides critical information on nuclear cardiology practice to better target and service our members’ needs. These data can prove invaluable to target educational needs and inform healthcare policy of contemporary nuclear cardiology practice.
Literature
3.
go back to reference Tilkemeier PL, Cooke CD, Grossman GB, McCallister BD Jr, Ward RP (2009) ASNC Imaging Guidelines for Nuclear Cardiology Procedures: Standardized reporting of radionuclide myocardial perfusion and function. Am Soc Nucl Cardiol. doi:10.1007/s12350-009-9095-8. Tilkemeier PL, Cooke CD, Grossman GB, McCallister BD Jr, Ward RP (2009) ASNC Imaging Guidelines for Nuclear Cardiology Procedures: Standardized reporting of radionuclide myocardial perfusion and function. Am Soc Nucl Cardiol. doi:10.​1007/​s12350-009-9095-8.
4.
go back to reference Tilkemeier PL, Serber ER, Farrell MB. The nuclear cardiology report: Problems, predictors, and improvement. A report from the ICANL database. J Nucl Cardiol 2011;18:858-68.PubMedCrossRef Tilkemeier PL, Serber ER, Farrell MB. The nuclear cardiology report: Problems, predictors, and improvement. A report from the ICANL database. J Nucl Cardiol 2011;18:858-68.PubMedCrossRef
5.
go back to reference Thomas GS, Thompson RC, Miyamoto MI, et al. The RegEx trial: A randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging. J Nucl Cardiol 2009;16:63-72.PubMedCrossRef Thomas GS, Thompson RC, Miyamoto MI, et al. The RegEx trial: A randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging. J Nucl Cardiol 2009;16:63-72.PubMedCrossRef
6.
go back to reference Thomas GS, Tammelin BR, Schiffman GL, et al. Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol 2008;15:319-28.PubMedCrossRef Thomas GS, Tammelin BR, Schiffman GL, et al. Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol 2008;15:319-28.PubMedCrossRef
7.
go back to reference Cerqueira MD, Nguyen P, Staehr P, Underwood SR, Iskandrian AE. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging 2008;1:307-16.PubMedCrossRef Cerqueira MD, Nguyen P, Staehr P, Underwood SR, Iskandrian AE. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging 2008;1:307-16.PubMedCrossRef
8.
go back to reference Iskandrian AE, Bateman TM, Belardinelli L, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 2007;14:645-58.PubMedCrossRef Iskandrian AE, Bateman TM, Belardinelli L, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 2007;14:645-58.PubMedCrossRef
9.
go back to reference Hendel RC, Bateman TM, Cerqueira MD, et al. Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 2005;46:2069-75.PubMedCrossRef Hendel RC, Bateman TM, Cerqueira MD, et al. Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 2005;46:2069-75.PubMedCrossRef
10.
go back to reference Cerqueira MD, Allman KC, Ficaro EP, et al. Recommendations for reducing radiation exposure in myocardial perfusion imaging. J Nucl Cardiol 2010;17:709-18.PubMedCrossRef Cerqueira MD, Allman KC, Ficaro EP, et al. Recommendations for reducing radiation exposure in myocardial perfusion imaging. J Nucl Cardiol 2010;17:709-18.PubMedCrossRef
11.
go back to reference Einstein AJ. Radiation risk from cardiac CT and nuclear cardiology: Addressing concerns with innovative solutions. J Nucl Cardiol 2011;18:561.PubMedCrossRef Einstein AJ. Radiation risk from cardiac CT and nuclear cardiology: Addressing concerns with innovative solutions. J Nucl Cardiol 2011;18:561.PubMedCrossRef
12.
go back to reference Einstein AJ. Radiation risk from coronary artery disease imaging: How do different diagnostic tests compare? Heart 2008;94:1519-21.PubMedCrossRef Einstein AJ. Radiation risk from coronary artery disease imaging: How do different diagnostic tests compare? Heart 2008;94:1519-21.PubMedCrossRef
13.
go back to reference Jessup M, Albert NM, Lanfear DE, et al. ACCF/AHA/HFSA 2011 survey results: Current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation: A report of the ACCF Heart Failure and Transplant Committee, AHA Heart Failure and Transplantation Committee, and Heart Failure Society of America. J Am Coll Cardiol 2011;57:2115-24.PubMedCrossRef Jessup M, Albert NM, Lanfear DE, et al. ACCF/AHA/HFSA 2011 survey results: Current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation: A report of the ACCF Heart Failure and Transplant Committee, AHA Heart Failure and Transplantation Committee, and Heart Failure Society of America. J Am Coll Cardiol 2011;57:2115-24.PubMedCrossRef
14.
go back to reference Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2012 update: A report from the American Heart Association. Circulation 2012;125:e2-220.PubMedCrossRef Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2012 update: A report from the American Heart Association. Circulation 2012;125:e2-220.PubMedCrossRef
Metadata
Title
The evolving practice of nuclear cardiology: Results from the 2011 ASNC member survey
Authors
Peter Tilkemeier, MD
Jacqueline Green, MD, MPH
Andrew J. Einstein, MD, PhD
Reza Fazel, MD, MSc
Patricia Reames, RTR, CNMT, NCT
Leslee J. Shaw, PhD
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 6/2012
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-012-9624-8

Other articles of this Issue 6/2012

Journal of Nuclear Cardiology 6/2012 Go to the issue